Need Help?

The Southern African Human Genome Programme

The Southern African Human Genome Programme (SAHGP) is a national and regional initiative that aims to unlock the unique genetic character of southern African populations. Its vision is to improve quality of life through understanding human genetic diversity. It is timely to advance the SAHGP initiative since global genomic initiatives are increasingly pointing to populations in Africa, more specifically the San and Khoe from southern Africa, as harbouring the most ancient genetic signatures among the living populations of the world. Studies on African populations have already generated a wealth of information upon which the SAHGP can build. This information will be used to promote and support genomic research programmes both nationally and regionally to address critical questions that would benefit the people of our region. The SAHGP aims to make a significant contribution to the understanding of DNA variation among southern Africans and how this impacts on the health of the people of this region. Aims of the SAHGP: To develop capacity for genomic research in southern Africa; To establish sustainable resources for genomic research in the region; and To translate knowledge and information into improvements in human health in the region. The objective is to derive the maximum benefit from the SAHGP, and that the data should be widely shared with the scientific community for the benefit of the people of the sub-continent and beyond.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001003791 24
EGAD00010001418 Illumina 24
Publications Citations
Whole-genome sequencing for an enhanced understanding of genetic variation among South Africans.
Nat Commun 8: 2017 2062
59
Genetic substructure and complex demographic history of South African Bantu speakers.
Nat Commun 12: 2021 2080
29
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
Pharmacogenomics J 21: 2021 649-656
8
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations.
Front Pharmacol 12: 2021 634016
13
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations.
Clin Pharmacol Ther 113: 2023 643-659
3
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans.
Neurol Genet 9: 2023 e200077
1